- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT05367050
Impact of a Behavioral Tele-health Program on the Quality of Recovery for Patients Undergoing Total Joint Replacement Surgery
Impact of Daily, Digital and Behavioral Tele-health Tapering Program for Perioperative Surgical Patients Exposed to Opioids.
Przegląd badań
Status
Interwencja / Leczenie
Typ studiów
Zapisy (Oczekiwany)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
California
-
Palo Alto, California, Stany Zjednoczone, 94304
- Rekrutacyjny
- Palo Alto Division - VA Palo Alto Health Care System
-
Kontakt:
- Kyle T Harrison, MD
- Numer telefonu: 650-996-6532
- E-mail: kharriso@stanford.edu
-
Kontakt:
- Nithya Vijayakumar, MS
- Numer telefonu: 6505146117
- E-mail: NVijayakumar@pavir.org
-
Główny śledczy:
- Kyle T Harrison, MD
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Male or female patients between the ages of 21-90 years old
- Patient is opioid naive i.e hasn't used opioid medication for 30 days prior to surgery
- Patient willing to use Lucid Lane program to provide behavioral health support for up to 4 weeks before surgery and 4 weeks after surgery.
- Patient is willing to discuss Lucid Lane progress with Palo Alto VA's medical team and prescribing clinicians.
- Patient is willing to sign a Lucid Lane Client Agreement.
- Patient is willing to sign an informed consent form
Exclusion Criteria:
- Serious mental illnesses including schizophrenia-spectrum disorders, severe bipolar disorder, and severe major depression.
- Active suicidal ideations
- Patient is on methadone or buprenorphine for treatment of opioid use disorder(i.e. for treatment of addiction, and not for treatment of pain)
- Patient unwilling to use or not possessing access to a device that allows for video visits(e.g. a smart phone, tablet, or computer)
- Patients who are in palliative care
- Unable to use English to participate in the consent process, the intervention or study assessments.
- Unable to provide informed consent to participate
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie podtrzymujące
- Przydział: Randomizowane
- Model interwencyjny: Zadanie krzyżowe
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Aktywny komparator: Treatment
Patients participate in the Lucid Lane therapy program including working with a mental health pain coach for up to 4 weeks before surgery and 4 weeks after surgery. All patients receive therapy provided by Lucid Lane, for 4 weeks after surgery |
This intervention is designed to aid participants with pre-surgery anxiety management and surgery prep and pain management post-surgery.
Participants will be assigned a Lucid Lane pain coach who will utilize mindfulness, cognitive behavioral therapy, group therapy, and mind-body therapies, to accomplish those goals.
|
|
Aktywny komparator: Control
Patients will participate in a a surgery preparedness course provided by the VA before surgery (Standard of Care) and Lucid Lane therapy after surgery All patients receive therapy provided by Lucid Lane, for 4 weeks after surgery |
This intervention is designed to aid participants with pre-surgery anxiety management and surgery prep and pain management post-surgery.
Participants will be assigned a Lucid Lane pain coach who will utilize mindfulness, cognitive behavioral therapy, group therapy, and mind-body therapies, to accomplish those goals.
This intervention is designed to help the participant prepare for their upcoming surgery.
Classes will include discussions around managing chronic pain before surgery, building mental resilience, dealing with the uncertainty of a new diagnosis or treatment plan, questions to ask their anesthesiologist before and on the day of surgery, what to expect during their potential stay at the hospital, and how to optimize their recovery after surgery.
Sessions will often include expert doctors who focus on surgery and medical management around it.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) or Hip Injury and Osteoarthritis Outcome Score (HOOS) and
Ramy czasowe: Up to 4 months
|
The KOOS and HOOS are questionnaires designed to assess short and long-term patient-relevant outcomes following knee/hip injury.
They are self-administered and assess five outcomes: pain, symptoms, activities of daily living, sport and recreation function, and knee/hip-related quality of life.
The scores are normalized on a scale of 0 to 100, where 0 indicates severe problems and 100 indicates no problems.
|
Up to 4 months
|
|
Change in Pain Catastrophizing scale
Ramy czasowe: Up to 4 months
|
The Pain catastrophizing scale (PCS) is a self administered, 13-item questionnaire, used to assess a patient's tendency to magnify the threat value of a pain stimulus.
It assess rumination, magnification and helplessness.
Responses are recorded on a scale of 0-4, where 0 represents absence of the thought and 4 represents the presence of the thought all the time.
The scale has a min score of 0 and a max score of 52.
A higher score indicates more pain catastrophizing .
|
Up to 4 months
|
|
Change in Depression Scores
Ramy czasowe: Up to 4 months
|
The Patient Health Questionnaire-9 (PHQ-9) is a 9-item self administered questionnaire used to screen and monitor the severity of depressive symptoms.
It inquires about depressive features, that align with the diagnostic and statistical manual of mental disorders, over the course of 2 weeks.
Responses are recorded on a scale of 0-3, where 0 represents absence of the symptom and 3 represents its presence nearly every day.
|
Up to 4 months
|
|
Change in Anxiety Scores
Ramy czasowe: Up to 4 months
|
The General Anxiety Disorder-7 (GAD-7) is a self administered, 7-item questionnaire used to measure general anxiety disorder and its severity.
Responses are recorded on a scale of 0-3, where 0 represents an absence of the symptom and 3 represents presence nearly every day.
|
Up to 4 months
|
Miary wyników drugorzędnych
Miara wyniku |
Ramy czasowe |
|---|---|
|
Percent tapered off opioid (50% MME)
Ramy czasowe: 4 weeks after surgery
|
4 weeks after surgery
|
Współpracownicy i badacze
Sponsor
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Oczekiwany)
Ukończenie studiów (Oczekiwany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 56984
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .